Trans-arterial chemoembolization (TACE)

PROCEDURE4 trials

Sponsors

Lahey Clinic, Ain Shams University, University of California, San Francisco

Conditions

HCCHepatoCellular CarcinomaHepatocellular CarcinomaMetastatic Prostate CancerProstate Cancer

Phase 1

177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer

RecruitingNCT07145177

University of California, San FranciscoMetastatic Prostate Cancer, Prostate Cancer

Start: 2026-03-16End: 2030-10-31Target: 30Updated: 2026-03-23

Phase 2

Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) as Bridge to Liver Transplant

CompletedNCT02182687

Lahey ClinicHCC, Hepatocellular Carcinoma

Start: 2014-06-30End: 2021-10-31Updated: 2024-03-05

Phase 3

Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant

TerminatedNCT03960008

Lahey ClinicHCC, Hepatocellular Carcinoma

Start: 2020-03-01End: 2024-02-28Updated: 2024-08-28

Phase 4

Efficacy and Safety of Drug Eluting Beads TACE in Treatment of HCC in Egyptian Patients

CompletedNCT03007225

Ain Shams UniversityHepatoCellular Carcinoma

Start: 2015-07-31End: 2016-08-31Updated: 2020-10-22

Related Papers

A randomized phase II feasibility study of individualized stereotactic body radiation therapy (SBRT) versus transarterial chemoembolization (TACE) with DEBDOX beads as a bridge to transplant in hepatocellular carcinoma (HCC).

Journal of Clinical Oncology2020-05-2021 citations

Economic analysis of transarterial chemoembolization (TACE) versus stereotactic body radiotherapy (SBRT) for the treatment of hepatocellular carcinoma (HCC).

Journal of Clinical Oncology2018-02-014 citations

A randomized phase II study of individualized stereotactic body radiation therapy (SBRT) versus transarterial chemoembolization (TACE) with DEBDOX beads as a bridge to transplant in hepatocellular carcinoma (HCC).

Journal of Clinical Oncology2017-02-0121 citations